Flavonoid-derived Privileged Scaffolds in anti-Trypanosoma brucei Drug Discovery
Domain:
healthcareRecord type:
paper
Creator:
PonFer
Publisher:
Ben
Host:
Objective:
Human African Trypanosomiasis (HAT), also known as sleeping sickness is
one of the 20 neglected tropical diseases listed by the World Health Organization, which lead to death
if left untreated. This disease is caused by Trypanosoma brucei gambiense, which is the chronic form
of the disease present in western and central Africa, and by T. brucei rhodesiense, which is the
acute form of the disease located in eastern and southern Africa. Many reports have highlighted the
effectiveness of flavonoid-based compounds against T. brucei.
Methods:
A literature search was conducted for naturally occurring and synthetic anti-T brucei flavonoids
by referencing textbooks and scientific databases (SciFinder, PubMed, Science Direct,
Wiley, ACS, SciELO, Google Scholar, Springer, among others) from their inception until February
2019.
Results:
The present review summarizes the current standings and perspectives for the use of flavonoids
as lead compounds for the potential treatment of HAT.
Conclusion:
Flavonoids isolated from different parts of plants and species were reported to exhibit moderate
to high in vitro antitrypanosomal activity against T. brucei. In addition, synthetic flavonoids revealed
anti-T. brucei activity. Molecular interactions of bioactive flavonoids with T. brucei protein
targets showed promising results.
Similar
Fragment-Based Drug Discovery for<i>Trypanosoma brucei</i>Glycosylphosphatidylinositol-Specific Phospholipase C through Biochemical and WaterLOGSY-NMR MethodsThe Role of Folate Transport in Antifolate Drug Action in Trypanosoma bruceiDivergent metabolism between
<i>Trypanosoma congolense</i>
and
<i>Trypanosoma brucei</i>
results in differential drug sensitivityPseudogene-derived small interference RNAs regulate gene expression in African
<i>Trypanosoma brucei</i>Discovery of trypanocidal coumarins with dual inhibition of both the glycerol kinase and alternative oxidase of
<i>Trypanosoma brucei brucei</i>Anti-diabetic drug discovery using bioactive compounds: Molecular docking insights